Chronic urticaria: diagnosis and management

Chronic urticaria (CU) is a prevalent skin condition that affects patients for extended periods. While its impact on quality of life is well-documented, the approach to diagnosis and treatment remains inconsistent among clinicians. Prior research has shown that CU can persist for months or years, often without a clear cause. The condition is associated with physical symptoms and emotional distress, yet diagnostic tools remain limited. Established knowledge includes the recognition of CU subtypes, such as idiopathic and autoimmune forms. However, no prior work had resolved the variability in diagnostic strategies across clinical settings. That uncertainty drove the need for a standardized, evidence-based approach to evaluation and treatment. This gap motivated a synthesis of literature to guide allergists in managing CU effectively.

The aim of this review is to provide a structured, evidence-based framework for diagnosing and managing chronic urticaria. The specific problem addressed is the lack of consistency in diagnostic and treatment protocols among allergists. Chronic urticaria presents diagnostic challenges due to overlapping subtypes and unclear etiologies. This uncertainty complicates patient care and treatment outcomes. The motivation for this review is to consolidate existing literature into a practical guide for clinicians. By synthesizing findings on natural history, subtypes, and treatment options, the study seeks to standardize care. A detailed history is emphasized as a diagnostic tool, while diagnostic tests are found to have limited utility. The ultimate goal is to improve patient quality of life through targeted interventions.

The authors conducted a comprehensive literature review focusing on chronic urticaria. They analyzed studies on natural history, subtypes, diagnostic approaches, and treatment strategies. The review included data on the impact of CU on quality of life and patient outcomes. No new experiments were performed; instead, the authors synthesized findings from existing publications. They examined variations in disease duration based on referral centers and subtypes. The literature was evaluated for evidence on diagnostic tools and treatment efficacy. Particular attention was given to the role of antihistamines and alternative therapies. The authors emphasized the importance of patient history in guiding diagnosis.

The review found that physical urticarias tend to persist longer than idiopathic forms of CU. Quality of life is significantly impacted, comparable to other chronic diseases. Idiopathic, autoimmune, and physical urticarias are the most common subtypes identified. Routine laboratory tests were found to have limited diagnostic value in most cases. Antihistamines, especially first-generation agents, are recommended as first-line treatment. Higher doses may be necessary to achieve adequate symptom control. Alternative agents are available for patients who do not respond to antihistamines. A detailed patient history remains the most effective diagnostic tool for identifying potential causes.

The synthesis of literature suggests that a detailed patient history is crucial for diagnosing chronic urticaria. The authors propose that routine diagnostic tests offer limited benefit in most cases. First-generation antihistamines are recommended as initial treatment, with higher doses potentially needed. Alternative therapies are available for patients with antihistamine-resistant urticaria. The goal of treatment should be to reduce symptoms and improve quality of life. Minimizing medication side effects and avoiding chronic corticosteroid use is emphasized. The authors suggest that diagnostic strategies should focus on patient history rather than extensive testing. These findings aim to guide allergists in providing consistent, evidence-based care.